Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data.
about
Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: BloodImpact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.Multi-state analysis illustrates treatment success after stem cell transplantation for acute myeloid leukemia followed by donor lymphocyte infusionSurvival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators.Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.Using multiple timescale models for the evaluation of a time-dependent treatment.Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM.Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P2860
Q34217884-C8E70B00-F722-4A53-AE92-4122CB057472Q35634902-9291B7BC-B30A-4D79-A7BB-FB23166DE030Q37216280-599BA42B-972E-40FB-A45A-B9DC61A0692BQ38616796-F95AA985-5F70-4AB4-9D51-12C869AF5F63Q38893877-41AA7308-4885-4A8F-913E-BFAB2741DA1BQ40690585-04B53A5B-D50B-45A4-8F06-417D6D359373Q48101262-FA248CA2-17D5-4711-9714-5FABCE161078Q48226649-60EBB853-5527-4524-B529-8E07E13C02EAQ55969986-BBD944B9-4D87-4222-9099-7FE1B4F6D6BF
P2860
Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Comparison of allogeneic stem ...... lts using non-randomized data.
@ast
Comparison of allogeneic stem ...... lts using non-randomized data.
@en
type
label
Comparison of allogeneic stem ...... lts using non-randomized data.
@ast
Comparison of allogeneic stem ...... lts using non-randomized data.
@en
prefLabel
Comparison of allogeneic stem ...... lts using non-randomized data.
@ast
Comparison of allogeneic stem ...... lts using non-randomized data.
@en
P2093
P2860
P50
P1433
P1476
Comparison of allogeneic stem ...... lts using non-randomized data.
@en
P2093
Anja van Biezen
Argiris Symeonidis
Christoph Schmid
Dietger Niederwieser
Francesco Onida
Ghulam Mufti
Guido Kobbe
Jürgen Finke
Laurent Garderet
Marie Robin
P2860
P304
P356
10.1371/JOURNAL.PONE.0074368
P407
P577
2013-10-07T00:00:00Z